← Back to Search

Unaided condition for Single-Sided Deafness

N/A

Waitlist Available

Led By Susan Scollie

Research Sponsored by Sonova AG

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 months

Awards & highlights

Study Summary

This trial will test whether the BiCROS hearing aid system helps people with one-sided hearing loss better hear speech.

Eligible Conditions

Single-Sided Deafness

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Speech intelligibility in Noise measured with US Matrix Test (noise from a defined loudspeaker)

Secondary outcome measures

Listening effort in noise using 7 point scale (Johnson et al, 2015)

Reports of Subjective quality of hearing as assessed by the Bern Benefit Questionnaires

Reports of Subjective quality of hearing as assessed by the SSQ

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Speech Intelligibility with CROS deviceExperimental Treatment3 Interventions

The focus of this study is on Speech Intelligibility (SI), evaluated by the US Matrix Test, which measures a speech recognition threshold (SRT) in dB SNR (signal to noise ratio). Therefore each participant will perform the tests with the experimental rechargeable CROS transmitter (CROS) in different interventions, like comparison to monaural fitting and unaided condition. All participants will perform the same tests. The order of the intervention in the speech test is randomized, but will be performed in the same visit by each participant.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sonova AGLead Sponsor

78 Previous Clinical Trials

1,848 Total Patients Enrolled

University of Western Ontario, CanadaOTHER

164 Previous Clinical Trials

319,227 Total Patients Enrolled

Western University, CanadaOTHER

239 Previous Clinical Trials

57,464 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of this experiment?

"Affirmative. Clinicaltrials.gov discloses that this research is in the process of seeking out subjects, with its first post on July 11th 2022 and last edit on October 13th 2022. The experiment desires 23 participants from two distinct medical sites."

Answered by AI

Is participation in this clinical experiment open to new volunteers?

"This clinical trial calls for 23 volunteers with unilateral hearing loss and aged 18-99. All potential participants must meet these requirements to be accepted into the study."

Answered by AI

Is the eligibility criteria for this trial restricted to those over twenty years old?

"This study is seeking individuals between 18 and 99 years old. For those under the age of 18, there are 34 clinical trials available; however, 71 other studies welcome participants over the age of 65."

Answered by AI

Are there currently any open slots for participants in this experiment?

"Data hosted on clinicaltrials.gov points to the fact that this research is currently recruiting participants. The study was posted publicly on July 11th 2022 and has been amended as recently as October 13th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of BiCROS Fitting Benefits

2022. "Evaluation of BiCROS Fitting Benefits". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05379231.